Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 9 studies | 46% ± 13% | |
respiratory goblet cell | 4 studies | 24% ± 8% | |
luminal cell of prostate epithelium | 4 studies | 25% ± 6% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 42% ± 16% |
Insufficient scRNA-seq data for expression of SPDEF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 97% | 13021.33 | 238 / 245 | 100% | 1306.61 | 501 / 502 |
breast | 65% | 3686.59 | 298 / 459 | 84% | 363.15 | 944 / 1118 |
stomach | 76% | 2161.11 | 274 / 359 | 27% | 27.78 | 78 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 46.66 | 1 / 1 |
intestine | 53% | 976.25 | 515 / 966 | 31% | 39.75 | 166 / 527 |
skin | 62% | 518.88 | 1130 / 1809 | 0% | 0.15 | 1 / 472 |
lung | 35% | 93.94 | 205 / 578 | 27% | 31.98 | 314 / 1155 |
pancreas | 8% | 15.55 | 27 / 328 | 40% | 43.64 | 72 / 178 |
uterus | 18% | 146.01 | 31 / 170 | 20% | 43.42 | 92 / 459 |
brain | 38% | 58.40 | 995 / 2642 | 0% | 0 | 0 / 705 |
ovary | 1% | 1.81 | 2 / 180 | 30% | 38.16 | 128 / 430 |
esophagus | 10% | 68.61 | 138 / 1445 | 16% | 16.34 | 30 / 183 |
bladder | 5% | 15.81 | 1 / 21 | 13% | 14.82 | 67 / 504 |
adipose | 3% | 17.82 | 35 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 4.12 | 1 / 45 |
liver | 0% | 0 | 0 / 226 | 2% | 3.21 | 8 / 406 |
muscle | 2% | 2.94 | 15 / 803 | 0% | 0 | 0 / 0 |
heart | 1% | 2.99 | 10 / 861 | 0% | 0 | 0 / 0 |
thymus | 1% | 1.30 | 4 / 653 | 0% | 0 | 0 / 605 |
blood vessel | 1% | 2.69 | 7 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 2.62 | 1 / 258 | 0% | 0 | 0 / 230 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.39 | 3 / 901 |
peripheral blood | 0% | 9.71 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0010455 | Biological process | positive regulation of cell fate commitment |
GO_0010454 | Biological process | negative regulation of cell fate commitment |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0060480 | Biological process | lung goblet cell differentiation |
GO_0072148 | Biological process | epithelial cell fate commitment |
GO_0060576 | Biological process | intestinal epithelial cell development |
GO_0030154 | Biological process | cell differentiation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0002068 | Biological process | glandular epithelial cell development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
Gene name | SPDEF |
Protein name | SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor) (Prostate-specific Ets) (Prostate-derived Ets factor) |
Synonyms | PDEF PSE |
Description | FUNCTION: May function as an androgen-independent transactivator of the prostate-specific antigen (PSA) promoter. Binds to 5'-GGAT-3' DNA sequences. May play a role in the regulation of the prostate gland and/or prostate cancer development. Acts as a transcriptional activator for SERPINB5 promoter. . |
Accessions | ENST00000374037.8 [O95238-1] O95238 ENST00000544425.2 [O95238-2] |